Scientific journal
When you publish your research results in a scientific journal, please refer to the origin of materials that were provided from RIKEN BRC and used in your research subject. We appreciate your cooperation.
Example :
(name of BIOLOGICAL RESOURCE) was provided by the RIKEN BRC through the National BioResource Project of the MEXT/AMED, Japan. Please also visit NBRP Reference List.
| Title | Auther | Journal | NBRP RRC ID |
|---|---|---|---|
| METHOD FOR INDUCING ANTIGEN SPECIFIC CD8 POSITIVE T CELLS | Kawamoto, H., Maeda, T., Masuda, K. | Patent publication US 2019 / 0161727 A1 | 1442 |
| Ckap4-molecular-targeted antitumor agent. | Kikuchi, A., Fumoto, K., Kimura, H. | United States Patent Application Publication US 2018/0037649 A1. | 985 |
| CELL CULTURE METHOD, CELL AGGREGATES, CELL AGGREGATION CONTROL AGENT, AND MEDIUM | Sakai, Y., Horiguchi, I., Matsunaga, K., Hayasaka, S. | United States Patent Application US 2018/0023057 A1 (2018). | 982 |
| METHOD FOR QUANTIFYING TARGET NUCLEIC ACID AND KIT THEREFOR | Hoshino, T., Inagaki, F. | US 2018/0320227 A1 | 1428 |
| Methods And Materials For Obtaining Hepatocyte Lineage Cells. | Tomizawa, M. | United States Patent Application Publication US2017/0218394 A1. | 981 |
| PRODUCTION METHOD FOR PLURIPOTENT STEM CELLS HAVING ANTIGEN-SPECIFIC T CELL RECEPTOR GENE | Kawamoto, H., Kaneko, S., Masuda, K., Maeda, T., Nagano, S., Katsura, Y. | United States Patent Application Publication US 2017/0267972 A1. | 980 |
| METHOD OF SCREENING ATP11C OR CDC50A INHIBITOR | Nagata, S., Segawa,K. | US Patent 20,170,023,548, 2017 | 979 |
| NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | Kataoka, K., Osada, K., Tockary, T.A. | US Patent Application Publication US 2016/0184457 A1 | 988 |
| THERAPEUTIC AGENT FOR SYSTEMIC BONE DISEASE AND USE THEREOF | Ohno, K., Ishiguro, N.,, Kito, H., Matsushita, M. | US Patent 20,150,216,860, 2015 | 991 |
| METHOD OF PRODUCING MYELOID BLOOD CELLS | Senju, S. | US Patent 20,130,195,818, 2013 | 930 |
| Expression vector | Shimatani-Shibata, Y., Yonekura, H.,Shimizu, H. | United States Patent Application 20,130,122,582, 2013 | |
| TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1. | Ogura, K. | K Ogura – US Patent 20,130,190,240, 2013 | |
| Coryneform bacterium transformant and process for producing phenol using the same | Yukawa, H., Inui, M. | Patent Application Publication WO 2012033112 A1 | 994 |
| Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter. | Kosai, K., Kamizono, J., Nagano, S. | United States Patent Application 20120230954 (2012). | |
| Nucleic acid construct for expressing oxidative stress indicator and use thereof | Takao IWAWAKI, Daisuke Oikawa | CN103298938A, EP2666857A1, US20130298263 | |
| Viral vector for gene therapy | Tani, K., Inoue, H., Inoue, M., Kinoh, H., Hasegawa, M. | United States Patent Application, 20100203027 (2010). | |
| Anaerobic bacterium as a drug for cancer gene therapy. | Fujimori, M., Taniguchi, S., Amano, J., Yazawa, K., Kano, Y. | United States Patent 7740835; publication data, 06/22/2010 | |
| Methods of treatment involving p21/CIP1 | Miyasaka, N., Kohsaka, H. | United States Patent Application 20100310508 | |
| Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter. | Kamizono J., Nagano S., Kosai K. | United States Patent Application 20090181907 (2009). | |
| Reversibly immortalized mammalian liver cells and use thereof. | Kobayashi, N., Tanaka, N., Kohara, M. | United States Patent Application, 20090148424 (2009). | |
| Method of constructing gene transport support. | Shimatani, Y., Hamaji, Y., Matsuhashi, H., Amano, J., Taniguchi, S., Fujimori, M. | United States Patent Application 20090169516 (2009). | |
| Expression vector | Shimatani-Shibata, Y., Yonekura, H.,Shimizu, H. | United States Patent Application 20090264513 (2009). | |
| 5-Fluorouracil-resistant bacteria and method for production thereof. | Hamaji, Y., Fujimori, M., Amano, J., Taniguchi, S. | United States Patent Application 20090280091 | |
| Method of measuring human CYP3A inducibility. | Yamazoe, Y., Nagata, K. | United States Patent Application 20090029351 | |
| PROCESS FOR PRODUCTION OF beta-ALANYLAMINO ACID OR DERIVATIVE THEREOF. | TAKESHITA, R., TAKAKURA, Y., SUZUKI, S., YOKOZEKI, K. | WO2009-139392 (2009). | |
| THERAPEUTIC AGENT FOR ANAEROBIC DISEASES. | Sasaki, T., Shimizu, H., Shimatani-Shibata, Y., Yonekura, H. | US Patent Application 20110110893, (2011). | |
| Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair. | Hayashi S. (Nagoya-shi, JP), Inoue M. (Tsukuba-shi, JP), Hasegawa M. (Tsukuba-shi, JP) | United States Patent Application 20080038234 (2008). | |
| Pluripotent stem cell growing method. | Akaike T. (Tokyo, JP), Fukuda K. (Tokyo, JP), Nagaoka M. (Kanagawa, JP), Koshimizu U. (Osaka, JP) | United States Patent 7,892,835, (2011); United States Patent Application 20070155013 (2007). | |
| Blood cholesterol level reducing substance. | SHINSHU UNIV (UICHI IKEDA, MASAFUMI TAKAHASHI, TORU YOSHIOKA, TAKANARI OZAWA, NAOMI OKADA, KAZUYUKI SHIMADA, KIICHI MAEDA, MASAHISA SHINPO) | Patent abstracts of Japan, 2006-028085 (2006). | |
| Method of proliferating pluripotent stem cell. | Akaike T. (Tokyo, JP) Fukuda K. (Tokyo, JP), Nagaoka M. (Kanagawa, JP), Koshimizu U. (Osaka, JP) | Europian Patent Application, EP-A1-1734112 (2006). | |
| Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof. | Kobayashi, N., Leboulch, P., Tanaka, N., Fujiwara, T., Totsugawa, T. | United States Patent 7033744 (2006) | |
| Use of geldanamycin and related compounds for treatment of fibrogenic disorders. | Strehlow D. | United States Patent Number: 6,887,853. Issued on 05/03/2005 to Strehlow. | |
| Method for efficiently preparing proliferation control type recombinant adenoviral vector and kit for preparing the same vector. | NAGOYA INDUSTRIAL SCIENCE RESEARCH INST (KENICHIRO KOSAI, SATOSHI NAGANO) | Patent abstracts of Japan, 2005-046101 (2005) | |
| Method of proliferating pluripotent stem cell. | Nagaoka M., Koshimizu U., Akaike T., Fukuda K. | Canadian Patent, 2560581 (2005). | |
| Reversibly immortalized hepatocytes and methods of use. | Fox I., LcBoulch P., Kobayashi N. | United States Patent Application, 20020081283 (2002). | |
| Adenovirus vector. | HOKKAIDO TECHNOLOGY LICENCE OFFICE CO LTD (HIROFUMI HAMADA, TAKASHI NAKAMURA) | Patent Abstracts of Japan, 2002-330789 (2002). | |
| p21Cip1 remedies for rheumatism. | Miyasaka, N., Kohsaka, H. | WIPO, WO2001021793 A1 | |
| Polynucleotide encoding secretory membrane protein. | Kimura, N., Toyoshima, T. | United States Patent 6271366 (Application 09/411722) (2001). |
(2019.11.25 T.M.)
2023.06.08
